Xtant Medical Holdings Inc (XTNT) stock coverage started with “Buy” in note to investors by Aegis

Xtant Medical Holdings Inc (NASDAQ: XTNT) shares rose on Wednesday Nov 30 with heavier trade volume than normal after more analysts initiated coverage on the stock.

Meanwhile, the Dow Jones Industrial Average hit an intraday record after opening higher Wednesday, led by the energy sector as hopes rose that the world’s major oil producers are near a deal on limiting output.

The benchmark S&P 500 and Dow were on track to post their largest monthly gains since March.

The S&P 500 SPX, +0.22% gained 5 points, or 0.2%, to 2,209. The Dow Jones Industrial Average DJIA, +0.41% added 62 points, or 0.3%, to 19,184, trading in record territory. The Nasdaq Composite COMP, -0.08% was 7 points, or 0.1%, higher at 5,386.

Analysts at Aegis initiated coverage on Xtant Medical Holdings Inc (NASDAQ: XTNT) stock, starting the company at Buy. With a rating of Buy on the stock, Xtant Medical Holdings Inc has a 52-week high of $3.75. The one-year price target of $4.00 is higher than the opening price of $0.51, resulting a number of other analysts to comment on the company in recent days. Changes in price targets are not unusual as analysts and brokerage firms will publish periodic updates after initiating coverage,.

Shares of Xtant Medical Holdings Inc (NASDAQ: XTNT) opened at $0.51 on Tuesday trading between $0.51 and $0.59, and last traded at $0.56, which is a spike of $0.07 or 13.48% over the previous closing price.

Xtant Medical Holdings Inc (NASDAQ: XTNT) currently has a market cap of 6.83M.

Xtant Medical Holdings Inc (NASDAQ: XTNT) Average Daily Trading Volume

538,200 shares traded hands yesterday, higher than the norm, out of a total float 6,300,000. Substantial gains in trading volume and price inflation together could mean excessive volume accumulation by institutional investors.

While increased trading for short periods will not mean much, conversely, a trend of heavy trading volume on the buy side over a series of days or weeks delivers a positive cue to market traders that institutions may be moving in, so institutional sponsorship is critical.

Institutional sponsorship just refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These professional investors have substantial teams of analysts that investigate thousands of stocks, so it is good validation to see them taking a postion in a stock you are considering.

Xtant Medical Holdings Inc (NASDAQ: XTNT) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By tracking the activity of these professional investors—and the moving averages they affect—it allows for traders to make more effective judgments on trades.

Trades for Xtant Medical Holdings Inc (NASDAQ: XTNT) have ranged from $0.45 – 3.75, and the stock now has a 50-day MA of $0.76 and 200-day MA of $1.44. Today’s last price is 85.07%% below the 52 week high of $3.75.

Indeed, earnings growth is among the most important things to look at in regards to stock investing and, accordingly, investors seek companies that have been successful at growing their earnings at least 25% or more for 3 consecutive years.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *